Treatment AdvancesDual Immunotherapy Is Now the Standard of Care. Here's What That Means for Mesothelioma Patients in 2026.Yvette AbregoJune 21, 2026 2 7
Treatment AdvancesBrigham and Women's Mesothelioma Program Is Expanding Access to Combination Immunotherapy for Patients Who Were Once Out of OptionsYvette AbregoJune 12, 2026 3 1
Treatment AdvancesIllinois Patients Gaining Faster Access to Immunotherapy Combos as Chicago-Area Oncologists Align With FDA-Approved ProtocolYvette AbregoMay 7, 2026 3 2
